Reinraum zur Produktion von Biologika bei WACKER in Jena: In den Fermentern werden mithilfe von Bakterien Wirkstoffproteine für Arzneimittel hergestellt – beispielsweise zur Behandlung von Krebs oder multipler Sklerose.

WACKER Invests in Jena Biotech Site

In Jena, the Munich-based chemical group WACKER has enhanced its production facilities for biopharmaceuticals – also known as biologics – with new equipment. Furthermore, an inspection by the Brazilian health authority ANVISA assessing the site’s quality standards was a major success. Both developments increase the appeal of the Jena site and offer benefits to customers.

Order photo